WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012093068) A PHARMACEUTICAL COMPOSITION OF A COMPLEX OF AN ANTI-DIG ANTIBODY AND DIGOXIGENIN THAT IS CONJUGATED TO A PEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/093068    International Application No.:    PCT/EP2011/074273
Publication Date: 12.07.2012 International Filing Date: 30.12.2011
IPC:
A61K 47/48 (2006.01), A61K 39/385 (2006.01), A61K 39/395 (2006.01), A61P 35/00 (2006.01), A61P 3/00 (2006.01), A61P 43/00 (2006.01)
Applicants: F. HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacher Strasse 124 CH-4070 Basel (CH) (For All Designated States Except US).
BRINKMANN, Ulrich [DE/DE]; (DE) (For US Only).
DZIADEK, Sebastian [DE/DE]; (DE) (For US Only).
HOFFMANN, Eike [DE/DE]; (DE) (For US Only)
Inventors: BRINKMANN, Ulrich; (DE).
DZIADEK, Sebastian; (DE).
HOFFMANN, Eike; (DE)
Agent: BURGER, Alexander; Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O. Box 11 52 82372 Penzberg (DE)
Priority Data:
11150037.7 03.01.2011 EP
Title (EN) A PHARMACEUTICAL COMPOSITION OF A COMPLEX OF AN ANTI-DIG ANTIBODY AND DIGOXIGENIN THAT IS CONJUGATED TO A PEPTIDE
(FR) COMPOSITION PHARMACEUTIQUE À BASE D'UN COMPLEXE ASSOCIANT UN ANTICORPS ANTI-DIG ET DE LA DIGOXIGÉNINE CONJUGUÉE À UN PEPTIDE
Abstract: front page image
(EN)The present invention relates to a pharmaceutical composition of complex of a monospecific antibody that binds to digoxigenin, and a digoxigenin-conjugated peptide, to the isolated or recovered complex as well as to a method of producing such complex or composition. Furthermore the use of such a pharmaceutical composition as a medicament is described.
(FR)La présente invention concerne une composition pharmaceutique à base d'un complexe associant un anticorps monospécifique qui se lie à la digoxigénine et un peptide conjugué à de la digoxigénine. L'invention porte, en outre, sur ledit complexe isolé ou recueilli, ainsi que sur un procédé de production dudit complexe ou de ladite composition. L'invention a également trait à l'utilisation de ladite composition pharmaceutique en tant que médicament.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)